Ads
related to: acute leukemia- Understanding Your MF
Discover what makes your MF unique.
See if a treatment may be for you.
- Dosing Information
Learn more about dosing &
how to take this treatment.
- Understanding Your MF
Search results
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and...
WTNH-TV New Haven· 2 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...
Earnings call: Syndax Pharmaceuticals outlines robust Q1 2024 performance
Investing.com· 2 days agoSyndax Pharmaceuticals , Inc. (NASDAQ: NASDAQ: SNDX ) has efficiently executed its corporate...
Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoKura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript May 4, 2024 Kura Oncology, Inc....
Penn Medicine wants stroke, heart, and other acute patients transferred to its hospitals as quickly...
Philly.com· 5 days agoThe ambulance that rescued Betty Hayes after her March stroke at a Lansdale church took her to Grand...
Biomolecular atlas for bone marrow offers unprecedented window into blood production
Medical Xpress· 4 days agoResearchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have revealed a powerful new bone marrow atlas that will offer ...
Syndax Pharmaceuticals Inc (SNDX) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 2 days agoA: Neil Gallagher, President and Head of R&D at Syndax, emphasized the importance of NCCN guidelines, noting that the initial approval for revumenib in KMT2A rearranged acute
Cwm LLC Purchases 1,358 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
ETF DAILY NEWS· 17 hours agoCwm LLC boosted its position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 415.3% during the fourth quarter, according to its most recent disclosure with the Securities and ...
Deerfield Management and Deerfield Foundation Announce Second Annual AML Summit and Recipients of...
The Pilot News· 4 days agoDeerfield Management and the Deerfield Foundation announced today they will honor the 2023-2024 recipients of the American Society of Hematology (ASH) Peter Steelman Scholar Award at the second ...
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Purchased by Zurcher Kantonalbank Zurich...
ETF DAILY NEWS· 5 days agoZurcher Kantonalbank Zurich Cantonalbank raised its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 9.0% in the fourth quarter, according to its most recent 13F filing ...
Kura Oncology (NASDAQ:KURA) Rating Reiterated by Wedbush
ETF DAILY NEWS· 6 days agoKura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a note issued to investors on Friday, Benzinga reports. Wedbush’s price target would ...